Filtered By:
Source: Reumatismo
Vaccination: Shingles (Herpes Zoster) Vaccine
This page shows you your search results in order of date.
Order by Relevance | Date
Total 222 results found since Jan 2013.
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1474.ABSTRACTNot available.PMID:35506319 | DOI:10.4081/reumatismo.2022.1474
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: J Finsterer Source Type: research
Reply to: "Herpes zoster seven days after SARS-CoV-2 vaccination in a patient with ankylosing spondylitis under adalimumab" by Josef Finsterer
Reumatismo. 2022 May 3;74(1). doi: 10.4081/reumatismo.2022.1482.ABSTRACTNot available.PMID:35506316 | DOI:10.4081/reumatismo.2022.1482
Source: Reumatismo - May 4, 2022 Category: Rheumatology Authors: B Maranini G Ciancio R Cultrera M Govoni Source Type: research
